3.815
price up icon1.16%   0.075
 
loading
전일 마감가:
$3.74
열려 있는:
$3.78
하루 거래량:
999.26K
Relative Volume:
0.28
시가총액:
$429.56M
수익:
$4.21M
순이익/손실:
$-97.67M
주가수익비율:
-4.1022
EPS:
-0.93
순현금흐름:
$-70.76M
1주 성능:
-9.27%
1개월 성능:
+42.77%
6개월 성능:
-10.56%
1년 성능:
-1.86%
1일 변동 폭
Value
$3.70
$3.8686
1주일 범위
Value
$3.5343
$4.31
52주 변동 폭
Value
$2.45
$6.72

Absci Corp Stock (ABSI) Company Profile

Name
명칭
Absci Corp
Name
전화
(360) 949-1041
Name
주소
18105 SE MILL PLAIN BLVD, VANCOUVER
Name
직원
156
Name
트위터
Name
다음 수익 날짜
2024-12-12
Name
최신 SEC 제출 서류
Name
ABSI's Discussions on Twitter

ABSI을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ABSI
Absci Corp
3.80 429.56M 4.21M -97.67M -70.76M -0.93
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
439.29 113.70B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
680.29 75.52B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
662.88 39.78B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
275.25 35.34B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
120.90 29.05B 3.30B -501.07M 1.03B -2.1146

Absci Corp Stock (ABSI) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-01-22 개시 Needham Buy
2024-10-02 개시 Guggenheim Buy
2024-07-03 개시 Morgan Stanley Overweight
2024-03-14 개시 Scotiabank Sector Outperform
2023-12-05 개시 KeyBanc Capital Markets Overweight
2023-05-04 개시 H.C. Wainwright Buy
2022-08-12 다운그레이드 JP Morgan Overweight → Underweight
2022-07-18 개시 Truist Buy
2022-03-02 재개 Cowen Market Perform
2022-02-01 개시 Berenberg Buy
2021-11-10 다운그레이드 BofA Securities Neutral → Underperform
2021-10-15 재개 Cowen Market Perform
2021-08-16 개시 BofA Securities Neutral
2021-08-16 개시 Cowen Market Perform
2021-08-16 개시 Credit Suisse Outperform
2021-08-16 개시 Stifel Hold
모두보기

Absci Corp 주식(ABSI)의 최신 뉴스

pulisher
Jan 28, 2025

Generative AI vs. cancer: Absci partners with Memorial Sloan Kettering for new therapeutics - MSN

Jan 28, 2025
pulisher
Jan 27, 2025

Ballentine Partners LLC Takes $27,000 Position in Absci Co. (NASDAQ:ABSI) - Defense World

Jan 27, 2025
pulisher
Jan 25, 2025

Absci (NASDAQ:ABSI) Earns Buy Rating from Analysts at Needham & Company LLC - Defense World

Jan 25, 2025
pulisher
Jan 25, 2025

Cathie Wood's ARK sells Accolade stock, buys more Absci - MSN

Jan 25, 2025
pulisher
Jan 24, 2025

Absci Corporation (ABSI): Pioneering AI-Driven Antibody Discovery with a ‘Buy’ Rating from Needham - Insider Monkey

Jan 24, 2025
pulisher
Jan 23, 2025

Cathie Wood's ARK sells Accolade stock, buys more Absci By Investing.com - Investing.com Australia

Jan 23, 2025
pulisher
Jan 23, 2025

Absci Stock Surges with “Buy” Ratings from HC Wainwright and Guggenheim: What Investors Should Know - HPBL

Jan 23, 2025
pulisher
Jan 23, 2025

Absci Corporation Soars 44% on Strategic AI Drug Discovery Partnership with AMD – Market - HPBL

Jan 23, 2025
pulisher
Jan 23, 2025

Absci Corporation and AMD Partner to Revolutionize AI-Driven Drug Discovery – Market - HPBL

Jan 23, 2025
pulisher
Jan 23, 2025

Absci (NASDAQ:ABSI) Now Covered by Needham & Company LLC - MarketBeat

Jan 23, 2025
pulisher
Jan 22, 2025

Needham Initiates Coverage of Absci (ABSI) with Buy Recommendation - MSN

Jan 22, 2025
pulisher
Jan 22, 2025

TSX Industrials EW Index (TXIE) QuotePress Release - The Globe and Mail

Jan 22, 2025
pulisher
Jan 22, 2025

KBW Premium Yield Equity REIT Index (KYX) QuotePress Release - The Globe and Mail

Jan 22, 2025
pulisher
Jan 22, 2025

TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail

Jan 22, 2025
pulisher
Jan 22, 2025

KBW Regional Banking Index (KRX) QuotePress Release - The Globe and Mail

Jan 22, 2025
pulisher
Jan 22, 2025

Absci shares jump as analyst lauds 'practical' AI drug company - The Business Journals

Jan 22, 2025
pulisher
Jan 22, 2025

Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales - Benzinga

Jan 22, 2025
pulisher
Jan 22, 2025

Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside - Benzinga

Jan 22, 2025
pulisher
Jan 22, 2025

Nasdaq Surges 1.5%; Procter & Gamble Posts Upbeat Earnings - Benzinga

Jan 22, 2025
pulisher
Jan 22, 2025

Needham initiates Absci shares with Buy rating on strategy By Investing.com - Investing.com Canada

Jan 22, 2025
pulisher
Jan 22, 2025

Needham initiates Absci shares with Buy rating on strategy - MSN

Jan 22, 2025
pulisher
Jan 22, 2025

Needham & Company LLC Begins Coverage on Absci (NASDAQ:ABSI) - MarketBeat

Jan 22, 2025
pulisher
Jan 22, 2025

Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference - GlobeNewswire

Jan 22, 2025
pulisher
Jan 22, 2025

This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga

Jan 22, 2025
pulisher
Jan 22, 2025

Cathie Wood's Ark Invest Buys Into Defense And Energy Stocks Amid Trump's Inaugural Policies - Benzinga

Jan 22, 2025
pulisher
Jan 22, 2025

Absci Corp (ABSI-Q) QuotePress Release - The Globe and Mail

Jan 22, 2025
pulisher
Jan 21, 2025

Absci Corporation Partners with AMD to Revolutionize AI-Powered Drug Discovery – Market - HPBL

Jan 21, 2025
pulisher
Jan 21, 2025

Absci partners with semiconductor company AMD for AI drug discovery - Mobihealth News

Jan 21, 2025
pulisher
Jan 21, 2025

Absci and Owkin synergise TechBio platforms to advance AI drug discovery - European Pharmaceutical Manufacturer

Jan 21, 2025
pulisher
Jan 20, 2025

AMD and Absci Collaborate to Revolutionize AI-Driven Drug Discovery – Market - HPBL

Jan 20, 2025
pulisher
Jan 20, 2025

Absci Co. (NASDAQ:ABSI) Short Interest Update - Defense World

Jan 20, 2025
pulisher
Jan 19, 2025

Absci stock reiterated at Buy at H.C. Wainwright on AI-drug discovery leadership - MSN

Jan 19, 2025
pulisher
Jan 18, 2025

Absci Shares Surge 27% on $20M Investment from AMD – Market - HPBL

Jan 18, 2025
pulisher
Jan 18, 2025

Absci Co. (NASDAQ:ABSI) Short Interest Up 10.5% in December - MarketBeat

Jan 18, 2025
pulisher
Jan 18, 2025

Barclays PLC Buys 104,083 Shares of Absci Co. (NASDAQ:ABSI) - MarketBeat

Jan 18, 2025
pulisher
Jan 17, 2025

Complete List of All AI Companies Under $2 Billion Market Cap - Insider Monkey

Jan 17, 2025
pulisher
Jan 17, 2025

Absci Corporation (ABSI): AI in Biopharma Discovery - Insider Monkey

Jan 17, 2025
pulisher
Jan 17, 2025

Absci Stock: A Deep Dive Into Analyst Perspectives (7 Ratings) - Benzinga

Jan 17, 2025
pulisher
Jan 17, 2025

Absci stock reiterated at Buy at H.C. Wainwright on AI-drug discovery leadership By Investing.com - Investing.com South Africa

Jan 17, 2025
pulisher
Jan 17, 2025

Absci Corporation Shares Surge on Strategic Partnership with AMD – Market - HPBL

Jan 17, 2025
pulisher
Jan 17, 2025

Absci's (ABSI) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Jan 17, 2025
pulisher
Jan 16, 2025

I: Weekly TechBio News - substack.com

Jan 16, 2025
pulisher
Jan 14, 2025

Thinking about buying stock in Hanryu Holdings, Absci Corp, Spero Therapeutics, BioXcel Therapeutics, or Cybin? - Marketscreener.com

Jan 14, 2025
pulisher
Jan 13, 2025

Absci Looks Cheap And Positioned For Growth With AMD’s AI Backing (NASDAQ:ABSI) - Seeking Alpha

Jan 13, 2025
pulisher
Jan 12, 2025

Absci rises after report on $20M investment by Advanced Micro Devices - MSN

Jan 12, 2025
pulisher
Jan 12, 2025

Absci Raising $20 Million From AMD - Pulse 2.0

Jan 12, 2025
pulisher
Jan 12, 2025

Catherine Wood's Strategic Acquisition of Absci Corp Shares - GuruFocus.com

Jan 12, 2025
pulisher
Jan 11, 2025

ABSIAbsci Corporation Latest Stock News & Market Updates - StockTitan

Jan 11, 2025
pulisher
Jan 11, 2025

Absci, Owkin announce partnership to bring together AI platforms - Yahoo Finance

Jan 11, 2025
pulisher
Jan 11, 2025

Absci Corporation and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery - Marketscreener.com

Jan 11, 2025

Absci Corp (ABSI) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$41.55
price up icon 1.69%
$22.34
price up icon 3.05%
$353.35
price down icon 5.38%
$5.3874
price up icon 3.45%
biotechnology ONC
$228.12
price up icon 0.53%
$122.33
price up icon 1.28%
자본화:     |  볼륨(24시간):